PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsHydatidiform mole
MeSH D006828 - hydatidiform mole
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D031901:Gestational trophoblastic disease
9 Companies
2 Drugs
$
Success rate
D006828: 
Hydatidiform mole
27 Companies
1 Drug
$
Success rate
D002820:Invasive hydatidiform mole
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
MylanMethotrexate Methotrexate  1992-05-15   
Rising PharmaceuticalsMethotrexate Methotrexate  2012-03-29   
SandozMethotrexate Methotrexate  2009-03-31   
Barr PharmaceuticalsMethotrexate Methotrexate  1990-10-15   
Methotrexate Trexall  2001-03-21   
Zydus TherapeuticsMethotrexate Methotrexate  2017-01-13   
Sun Pharmaceutical IndustriesMethotrexate Methotrexate  2015-05-21   
HospiraMethotrexate Methotrexate  1982-01-01   
Amneal PharmaceuticalsMethotrexate Methotrexate  2017-12-22   
Strides Pharma GlobalMethotrexate Methotrexate  1982-01-01   
Bristol Myers SquibbMethotrexate Mexate  1982-01-01   
Methotrexate Mexate-aq  1985-02-14   
Methotrexate Mexate-aq Preserved  1989-04-14   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/1
Phase 3
29%
2/7
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Barr Pharmaceuticals
Methotrexate
Amneal Pharmaceuticals
Methotrexate
Bristol Myers Squibb
Methotrexate
Pharmacia & Upjohn
Methotrexate
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use